Study could reveal whether breast cancer patients with BRCA mutations are responsive

[News]

Ongoing research at the Methodist Cancer Center could reveal whether metastatic breast cancer patients with BRCA gene mutations are particularly responsive to a drug regimen that includes Veliparib, an investigational drug believed to hamper cancer cells.

More... (http://www.news-medical.net/news/20120915/Study-could-reveal-whether-breast-cancer-patients-with-BRCA-mutations-are-responsive-to-Veliparib.aspx)